{
    "Trade/Device Name(s)": [
        "DiaSorin LIAISON\u00ae Treponema Assay"
    ],
    "Submitter Information": "DiaSorin Inc.",
    "510(k) Number": "K061247",
    "Predicate Device Reference 510(k) Number(s)": [
        "K014233"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP"
    ],
    "Summary Letter Date": "July 21, 2006",
    "Summary Letter Received Date": "July 24, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3830"
    ],
    "Regulation Name(s)": [
        "Enzyme\u2014linked immunoabsorption assay, Treponema pallidum"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Antibodies to Treponema pallidum"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "LIAISON\u00ae Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay (CLIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for DiaSorin LIAISON\u00ae Treponema Assay using chemiluminescence immunoassay technology for detection of Treponema pallidum antibodies in human serum",
    "Indications for Use Summary": "Qualitative detection of total antibodies (IgG/IgM) against Treponema pallidum in human serum to aid in the diagnosis of syphilis infection, not intended for screening blood or plasma donors",
    "fda_folder": "Microbiology"
}